My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 161

    1.

    Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterization.

    Mallone R, Ortolan E, Baj G, Funaro A, Giunti S, Lillaz E, Saccucci F, Cassader M, Cavallo-Perin P, Malavasi F.

    Diabetes. 2001 Apr;50(4):752-62.PMID: 11289039 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets.

    Pupilli C, Giannini S, Marchetti P, Lupi R, Antonelli A, Malavasi F, Takasawa S, Okamoto H, Ferrannini E.

    Diabetes. 1999 Dec;48(12):2309-15.PMID: 10580418 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.

    Mallone R, Ortolan E, Pinach S, Volante M, Zanone MM, Bruno G, Baj G, Lohmann T, Cavallo-Perin P, Malavasi F.

    Diabetologia. 2002 Dec;45(12):1667-77. Epub 2002 Oct 24.PMID: 12488956 [PubMed - indexed for MEDLINE]Related articles

    4.

    CD38 autoimmunity: recent advances and relevance to human diabetes.

    Antonelli A, Ferrannini E.

    J Endocrinol Invest. 2004 Jul-Aug;27(7):695-707. Review.PMID: 15505998 [PubMed - indexed for MEDLINE]Related articles

    5.

    A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro.

    Yagui K, Shimada F, Mimura M, Hashimoto N, Suzuki Y, Tokuyama Y, Nata K, Tohgo A, Ikehata F, Takasawa S, Okamoto H, Makino H, Saito Y, Kanatsuka A.

    Diabetologia. 1998 Sep;41(9):1024-8.PMID: 9754820 [PubMed - indexed for MEDLINE]Related articles

    6.

    Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.

    Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini E.

    Diabetologia. 2002 Sep;45(9):1298-306. Epub 2002 Jul 24.PMID: 12242463 [PubMed - indexed for MEDLINE]Related articles

    7.

    Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.

    Ikehata F, Satoh J, Nata K, Tohgo A, Nakazawa T, Kato I, Kobayashi S, Akiyama T, Takasawa S, Toyota T, Okamoto H.

    J Clin Invest. 1998 Jul 15;102(2):395-401.PMID: 9664081 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets.

    Antonelli A, Baj G, Marchetti P, Fallahi P, Surico N, Pupilli C, Malavasi F, Ferrannini E.

    Diabetes. 2001 May;50(5):985-91.PMID: 11334442 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.

    Antonelli A, Fallahi P, Nesti C, Pupilli C, Marchetti P, Takasawa S, Okamoto H, Ferrannini E.

    Clin Exp Immunol. 2001 Dec;126(3):426-31.PMID: 11737057 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Anti-CD38 autoantibodies in type? diabetes.

    Mallone R, Perin PC.

    Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):284-94. Review.PMID: 16544364 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.

    Sordi V, Lampasona V, Cainarca S, Bonifacio E.

    Diabet Med. 2005 Dec;22(12):1770-3.PMID: 16401328 [PubMed - indexed for MEDLINE]Related articles

    12.

    The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene.

    Ferrero E, Saccucci F, Malavasi F.

    Immunogenetics. 1999 Jul;49(7-8):597-604.PMID: 10369916 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cyclic ADP-ribose-mediated insulin secretion and Reg, regenerating gene.

    Okamoto H.

    J Mol Med. 1999 Jan;77(1):74-8.PMID: 9930932 [PubMed - indexed for MEDLINE]Related articles

    14.

    Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells.

    Deaglio S, Zubiaur M, Gregorini A, Bottarel F, Ausiello CM, Dianzani U, Sancho J, Malavasi F.

    Blood. 2002 Apr 1;99(7):2490-8.PMID: 11895784 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals.

    Schlosser M, Strebelow M, Wassmuth R, Arnold ML, Breunig I, Rjasanowski I, Ziegler B, Ziegler M.

    J Clin Endocrinol Metab. 2002 May;87(5):2254-61.PMID: 11994372 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Human CD38, a surface receptor, an enzyme, an adhesion molecule and not a simple marker.

    Funaro A, Malavasi F.

    J Biol Regul Homeost Agents. 1999 Jan-Mar;13(1):54-61. Review.PMID: 10432444 [PubMed - indexed for MEDLINE]Related articles

    17.

    CD38: a new paradigm in lymphocyte activation and signal transduction.

    Lund FE, Cockayne DA, Randall TD, Solvason N, Schuber F, Howard MC.

    Immunol Rev. 1998 Feb;161:79-93. Review.PMID: 9553766 [PubMed - indexed for MEDLINE]Related articles

    18.

    CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines.

    Musso T, Deaglio S, Franco L, Calosso L, Badolato R, Garbarino G, Dianzani U, Malavasi F.

    J Leukoc Biol. 2001 Apr;69(4):605-12.PMID: 11310847 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system.

    Okamoto H, Takasawa S, Nata K, Kato I, Tohgo A, Noguchi N.

    Chem Immunol. 2000;75:121-45. Review. No abstract available. PMID: 10851782 [PubMed - indexed for MEDLINE]Related articles

    20.

    Signaling through CD38 induces NK cell activation.

    Mallone R, Funaro A, Zubiaur M, Baj G, Ausiello CM, Tacchetti C, Sancho J, Grossi C, Malavasi F.

    Int Immunol. 2001 Apr;13(4):397-409.PMID: 11282979 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity